BRESCIANI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 10.469
AS - Asia 5.377
EU - Europa 4.412
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 107
OC - Oceania 10
Totale 21.502
Nazione #
US - Stati Uniti d'America 10.044
SG - Singapore 1.620
IT - Italia 1.368
VN - Vietnam 1.296
CN - Cina 1.068
DE - Germania 694
HK - Hong Kong 577
RU - Federazione Russa 533
BR - Brasile 515
CA - Canada 337
SE - Svezia 318
IE - Irlanda 311
GB - Regno Unito 255
UA - Ucraina 211
IN - India 175
FR - Francia 153
FI - Finlandia 134
AT - Austria 102
BD - Bangladesh 91
ID - Indonesia 89
KR - Corea 85
AR - Argentina 61
TR - Turchia 60
PL - Polonia 56
NL - Olanda 51
IQ - Iraq 47
JP - Giappone 43
BE - Belgio 42
ES - Italia 41
MX - Messico 41
CO - Colombia 40
DK - Danimarca 39
ZA - Sudafrica 34
CH - Svizzera 33
EC - Ecuador 31
PH - Filippine 30
PK - Pakistan 27
SA - Arabia Saudita 25
MY - Malesia 19
VE - Venezuela 19
UZ - Uzbekistan 18
KE - Kenya 17
JM - Giamaica 15
CR - Costa Rica 12
MA - Marocco 12
PY - Paraguay 12
TW - Taiwan 12
BG - Bulgaria 11
CZ - Repubblica Ceca 11
CL - Cile 10
IR - Iran 10
LT - Lituania 9
NP - Nepal 9
RO - Romania 9
EG - Egitto 8
HN - Honduras 8
LB - Libano 8
PS - Palestinian Territory 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
JO - Giordania 7
OM - Oman 7
PE - Perù 7
TN - Tunisia 7
UY - Uruguay 7
KZ - Kazakistan 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
EU - Europa 5
RS - Serbia 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
PT - Portogallo 4
GR - Grecia 3
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SN - Senegal 3
AO - Angola 2
GE - Georgia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
MR - Mauritania 2
NG - Nigeria 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
Totale 21.073
Città #
Ann Arbor 1.573
Ashburn 1.068
Singapore 1.004
San Jose 619
Hong Kong 563
Woodbridge 509
Wilmington 501
Frankfurt am Main 479
Chandler 445
Fairfield 436
Milan 425
Ho Chi Minh City 398
Hanoi 305
Dublin 300
Houston 262
Seattle 229
Beijing 221
New York 221
Jacksonville 194
Toronto 191
Los Angeles 180
Santa Clara 176
Council Bluffs 173
Dearborn 172
Dallas 168
Chicago 139
Cambridge 137
Princeton 116
Hefei 109
Vienna 90
The Dalles 89
Jakarta 78
Rome 76
Seoul 76
Nanjing 73
Helsinki 70
Buffalo 67
Lauterbourg 58
Shanghai 57
Moscow 56
Boardman 55
Da Nang 52
London 50
São Paulo 50
Columbus 49
Altamura 45
Haiphong 45
Lawrence 42
Phoenix 42
Brussels 40
Munich 40
Guangzhou 39
Tokyo 37
Kent 34
Denver 33
Lachine 32
Warsaw 31
Biên Hòa 29
Orem 29
San Diego 29
Nuremberg 28
Pune 28
Atlanta 27
Fremont 27
Baghdad 24
Brooklyn 24
Elora 23
Monza 23
Poplar 22
Ha Long 21
Nanchang 21
San Francisco 21
Andover 20
Can Tho 20
Dong Ket 20
Stockholm 20
Turin 20
Hải Dương 19
Montreal 19
Rio de Janeiro 19
Changsha 18
Shenyang 18
Tashkent 18
Turku 18
Bari 17
Detroit 17
Hebei 17
Sacramento 17
Zurich 17
Boston 16
Romola 16
Amsterdam 15
Johannesburg 15
Philadelphia 15
Quận Bình Thạnh 15
Ankara 14
Carate Brianza 14
Tampa 14
Thái Nguyên 14
Chennai 13
Totale 13.670
Nome #
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 559
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 559
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 546
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 526
Growth hormone secretagogues and the regulation of calcium signaling in muscle 494
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 485
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 477
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 476
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 409
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 406
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 394
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 373
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 359
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 359
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 355
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 354
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 349
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 343
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 342
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 333
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 328
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 324
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 321
Feeding behavior during long-term hexarelin administration in young and old rats 319
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 317
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 312
Ghrelin in gastroenteric pathophysiology 312
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 311
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 309
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 307
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 306
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 303
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 301
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 301
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 299
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 299
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 299
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 296
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 294
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 292
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 291
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 286
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 281
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 273
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 273
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 270
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 270
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 269
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 259
Androgen therapy in neurodegenerative diseases 253
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 249
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 249
The role of androgens in women's health and wellbeing 246
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 245
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 240
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 235
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 230
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 221
La somatopausa: nuove prospettive terapeutiche 221
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 221
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 220
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 216
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 188
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 184
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 168
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 164
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 154
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 148
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model 125
Role of nutrition in degenerative disease 120
Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant Epilepsy 85
Totale 21.502
Categoria #
all - tutte 65.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022687 0 0 0 83 56 75 46 46 30 86 96 169
2022/20231.866 186 484 216 182 142 268 31 118 115 19 56 49
2023/20241.156 38 58 67 77 134 281 218 52 74 23 21 113
2024/20252.808 153 234 213 189 234 166 220 133 168 376 237 485
2025/20267.807 1.294 689 578 780 809 361 1.008 313 616 608 372 379
2026/20271.576 184 298 665 429 0 0 0 0 0 0 0 0
Totale 21.502